Inactive Instrument
Five Prime Therapeutics, Inc. Share Price
Stocks
FPRX
US33830X1046
Biotechnology & Medical Research
| 1 day | +0.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Bradner
CEO | Chief Executive Officer | 53 | - |
Peter Griffith
DFI | Director of Finance/CFO | 67 | - |
Jonathan Graham
LAW | General Counsel | 65 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/04/21 | Issuer sale | Director | 45,000 | 0.0966% | ||
| 16/04/21 | Free | Chief Financial Officer | 5,69,947 | 1.2238% | ||
| 16/04/21 | Issuer sale | Chief Executive Officer | 5,48,971 | 1.1788% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.16% | - | - | 174.05Cr | |
| -4.83% | +3.51% | +53.62% | +61.75% | 6.59TCr | |
| -1.34% | +2.98% | +24.79% | +100.18% | 5.65TCr | |
| +0.02% | +1.07% | +10.63% | +76.66% | 5.69TCr | |
| +5.09% | +9.89% | +22.45% | +107.48% | 4.65TCr | |
| +2.62% | +1.68% | +28.91% | +37.01% | 4.48TCr | |
| +8.24% | +0.51% | +213.26% | +792.66% | 4.16TCr | |
| -1.86% | +10.13% | +26.82% | +53.22% | 3.53TCr | |
| -2.97% | -9.84% | +88.86% | +76.17% | 3.33TCr | |
| -2.18% | +7.06% | +36.06% | -4.95% | 2.49TCr | |
| Average | +0.28% | +3.25% | +56.16% | +144.47% | 4.51TCr | |
| Weighted average by Cap. | +0.21% | +3.40% | +53.12% | +142.96% |
Employees
51
